Challen Laura, Agbahiwe Sylvester, Cantieri Tara, Olivetti Jessica Garcia, Mbah Theophilus, Mendoza-Becerra Yvonne, Munoz Cesar, Nguyen Michelle, Partee Katashia, Lal Lincy, Thomas Jocelyn, Green Monica
Assistant Professor of Pharmacy Practice, St. Louis College of Pharmacy , St. Louis, Missouri.
Clinical Pharmacist II, Settegast Health Center , Houston, Texas.
Hosp Pharm. 2015 Oct;50(9):783-8. doi: 10.1310/hpj5009-783. Epub 2015 Oct 14.
Point-of-care (POC) testing devices allow laboratory monitoring to be performed in various settings and accessed immediately.
To evaluate the outcomes of monitoring anticoagulation patients in pharmacistmanaged, multicenter clinics utilizing i-STAT POC machines.
This study was a retrospective, multicenter chart review of 150 patients before and after implementation of the POC intervention for anticoagulation monitoring. Data collected included international normalized ratio (INR) results, indication for warfarin, minor and major bleeds, thromboembolic events, emergency room (ER) visits, and hospitalizations before and after i-STAT POC implementation.
The time in therapeutic INR range (TTR) was significantly higher after i-STAT POC implementation than before implementation (60.4% ± 21.2% and 52.5% ± 21.5%, respectively; P = .0001). There were no reports of major bleeding during the study period. Twenty-three minor bleeds were reported after i-STAT POC implementation compared to 19 events before implementation (P < .0001). One thromboembolic event was reported after i-STAT POC implementation. There was a significant difference in the number of hospitalizations before i-STAT POC implementation as opposed to after implementation (2 and 0, respectively; P < .0001). There was also a significant increase in ER visits after i-STAT POC implementation (P < .0001).
The results of the study indicate improvement in TTR in pharmacist-managed anticoagulation clinics by 7.8%. Although the use of the i-STAT POC machine detected an increase in minor bleeds, thromboembolic events, and ER visits, there was a decrease in hospitalization. The outcomes of this multicenter study indicate that implementation on this scale provides improvement in regard to safety and cost.
即时检验(POC)设备可在各种环境中进行实验室监测并能立即获取结果。
评估在药剂师管理的多中心诊所中使用i-STAT POC机器监测抗凝患者的结果。
本研究是一项回顾性多中心图表审查,对150例患者在实施POC抗凝监测干预前后的情况进行分析。收集的数据包括国际标准化比值(INR)结果、华法林使用指征、轻微和严重出血、血栓栓塞事件、实施i-STAT POC前后的急诊室(ER)就诊次数和住院情况。
实施i-STAT POC后,治疗性INR范围内的时间(TTR)显著高于实施前(分别为60.4%±21.2%和52.5%±21.5%;P = 0.0001)。研究期间无严重出血报告。实施i-STAT POC后报告了23例轻微出血事件,而实施前为19例(P < 0.0001)。实施i-STAT POC后报告了1例血栓栓塞事件。实施i-STAT POC前后的住院次数有显著差异(分别为2次和0次;P < 0.0001)。实施i-STAT POC后急诊室就诊次数也显著增加(P < 0.0001)。
研究结果表明,在药剂师管理的抗凝诊所中,TTR提高了7.8%。虽然使用i-STAT POC机器检测到轻微出血、血栓栓塞事件和急诊室就诊次数增加,但住院次数减少。这项多中心研究的结果表明,这种规模的实施在安全性和成本方面有所改善。